Canaccord Genuity Reiterates Buy Rating on LifeStance Health Group, Inc. (LFST)

Market Context

LifeStance Health Group, Inc. operates in the Healthcare sector. The stock currently trades at $13.77 with a market capitalization of $2.6B. The stock has gained 107.6% over the past 52 weeks.

Analyst coverage from Canaccord Genuity provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for LifeStance Health Group, Inc.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for LifeStance Health Group, Inc.

Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Nov 06, 2026	Canaccord Genuity	Buy	N/A
Nov 06, 2026	Keybanc	Overweight	N/A
Nov 05, 2026	BTIG	Buy	N/A
Oct 05, 2026	Keybanc	Overweight	N/A
Sep 10, 2026	Barclays	Overweight	N/A

Related Tools: Analyst Ratings Dashboard | View LFST Stock Page